Salem Investment Counselors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | -$2.14K | – | 1252 |
|
|
2024
Q4 | $2.14K | Hold |
3
| – | – | ﹤0.01% | 1011 |
|
|
2024
Q3 | $3.15K | Sell |
3
-15
| -83% | -$15.8K | ﹤0.01% | 975 |
|
|
2024
Q2 | $18.9K | Hold |
18
| – | – | ﹤0.01% | 726 |
|
|
2024
Q1 | $17.3K | Hold |
18
| – | – | ﹤0.01% | 742 |
|
|
2023
Q4 | $15.8K | Hold |
18
| – | – | ﹤0.01% | 732 |
|
|
2023
Q3 | $14.8K | Hold |
18
| – | – | ﹤0.01% | 723 |
|
|
2023
Q2 | $12.9K | Sell |
18
-150
| -89% | -$108K | ﹤0.01% | 780 |
|
|
2023
Q1 | $138K | Sell |
168
-105
| -38% | -$86.3K | 0.01% | 378 |
|
|
2022
Q4 | $197K | Buy |
273
+53
| +24% | +$38.2K | 0.01% | 329 |
|
|
2022
Q3 | $152K | Sell |
220
-855
| -80% | -$591K | 0.01% | 341 |
|
|
2022
Q2 | $635K | Buy |
1,075
+92
| +9% | +$54.3K | 0.03% | 216 |
|
|
2022
Q1 | $687K | Sell |
983
-100
| -9% | -$69.9K | 0.03% | 223 |
|
|
2021
Q4 | $684K | Buy |
1,083
+250
| +30% | +$158K | 0.02% | 240 |
|
|
2021
Q3 | $504K | Buy |
833
+286
| +52% | +$173K | 0.03% | 245 |
|
|
2021
Q2 | $306K | Buy |
547
+183
| +50% | +$102K | 0.02% | 285 |
|
|
2021
Q1 | $172K | Buy |
+364
| New | +$172K | 0.01% | 302 |
|
|
2017
Q4 | – | Sell |
-5
| Closed | -$2K | – | 576 |
|
|
2017
Q3 | $2K | Sell |
5
-4
| -44% | -$1.6K | ﹤0.01% | 525 |
|
|
2017
Q2 | $4K | Buy |
+9
| New | +$4K | ﹤0.01% | 537 |
|
|
2017
Q1 | – | Sell |
-6
| Closed | -$2K | – | 631 |
|
|
2016
Q4 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 623 |
|